Referencias

  1. Lopez-Quintero, C., et al., Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend, 2011. 115(1-2): p. 120-30.
  2. Hall, W. and L. Degenhardt, Adverse health effects of non-medical cannabis use. Lancet, 2009. 374(9698): p. 1383-91.
  3. Budney, A.J., J.D. Sargent, and D.C. Lee, Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction, 2015. 110(11): p. 1699-704.
  4. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5th ed., American Psychiatric Association, Editor. 2013, Arlington, VA.
  5. National Institute on Drug Abuse. Is marijuana addictive? [cited 2016 July 11 ,2016]; Available from: https://www.drugabuse.gov/publications/research-reports/marijuana/marijuana-addictiveExternal.
  6. Meier, M.H., et al., Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A, 2012. 109(40): p. E2657-64.
  7. Filbey, F.M., et al., Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A, 2014. 111(47): p. 16913-8.
  8. Goldschmidt, L., N.L. Day, and G.A. Richardson, Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol, 2000. 22(3): p. 325-36.
  9. Fried, P.A., B. Watkinson, and R. Gray, Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol, 1998. 20(3): p. 293-306.
  10. Leech, S.L., et al., Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds. Neurotoxicol Teratol, 1999. 21(2): p. 109-18.
  11. Goldschmidt, L., et al., Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry, 2008. 47(3): p. 254-63.
  12. El Marroun, H., et al., Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend, 2011. 118(2-3): p. 470-4.
  13. US Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General, Centers for Disease Control and Prevention, Editor. 2014: Atlanta, GA.
  14. Sidney, S., et al., Marijuana use and cancer incidence (California, United States). Cancer Causes Control, 1997. 8(5): p. 722-8.
  15. Gurney, J., et al., Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer, 2015. 15: p. 897.
  16. Sidney, S., Cardiovascular consequences of marijuana use. J Clin Pharmacol, 2002. 42(11 Suppl): p. 64S-70S.
  17. Aronow, W.S. and J. Cassidy, Effect of marihuana and placebo-marihuana smoking on angina pectoris. N Engl J Med, 1974. 291(2): p. 65-7.
  18. Mittleman, M.A., et al., Triggering myocardial infarction by marijuana. Circulation, 2001. 103(23): p. 2805-9.
  19. Wolff, V., et al., Cannabis-related stroke: myth or reality? Stroke, 2013. 44(2): p. 558-63.
  20. Wolff, V., et al., Characteristics and Prognosis of Ischemic Stroke in Young Cannabis Users Compared With Non-Cannabis Users. J Am Coll Cardiol, 2015. 66(18): p. 2052-3.
  21. Franz, C.A. and W.H. Frishman, Marijuana Use and Cardiovascular Disease. Cardiol Rev, 2016. 24(4): p. 158-62.
  22. Rumalla, K., A.Y. Reddy, and M.K. Mittal, Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci, 2016. 364: p. 191-6.
  23. Rumalla, K., A.Y. Reddy, and M.K. Mittal, Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis, 2016. 25(2): p. 452-60.
  24. Tashkin, D.P., Effects of marijuana smoking on the lung. Ann Am Thorac Soc, 2013. 10(3): p. 239-47.
  25. Moir, D., et al., A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol, 2008. 21(2): p. 494-502.
  26. Aldington, S., et al., Effects of cannabis on pulmonary structure, function and symptoms. Thorax, 2007. 62(12): p. 1058-63.
  27. Bloom, J.W., et al., Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed), 1987. 295(6612): p. 1516-8.
  28. Moore, C., et al., Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int, 2011. 212(1-3): p. 227-30.
  29. Tan, W.C., et al., Marijuana and chronic obstructive lung disease: a population-based study. CMAJ, 2009. 180(8): p. 814-20.
  30. Tashkin, D.P., et al., Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis, 1987. 135(1): p. 209-16.
  31. Taylor, D.R., et al., The respiratory effects of cannabis dependence in young adults. Addiction, 2000. 95(11): p. 1669-77.
  32. Hancox, R.J., et al., Effects of quitting cannabis on respiratory symptoms. Eur Respir J, 2015. 46(1): p. 80-7.
  33. Tashkin, D.P., M.S. Simmons, and C.H. Tseng, Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD, 2012. 9(4): p. 367-74.
  34. Cone, E.J., et al., Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J Anal Toxicol, 2015. 39(1): p. 1-12.
  35. Zarfin, Y., et al., Infant with altered consciousness after cannabis passive inhalation. Child Abuse Negl, 2012. 36(2): p. 81-3.
  36. National Institute on Drug Abuse, Marijuana, in Research Report Series. 2015, National Institutes of Health; U.S. Department of Health and Human Services.
  37. Large, M., et al., Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry, 2011. 68(6): p. 555-61.
  38. Arseneault, L., et al., Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ, 2002. 325(7374): p. 1212-3.
  39. Di Forti, M., et al., Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull, 2014. 40(6): p. 1509-17.
  40. Di Forti, M., et al., High-potency cannabis and the risk of psychosis. Br J Psychiatry, 2009. 195(6): p. 488-91.
  41. Di Forti, M., et al., Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry, 2015. 2(3): p. 233-8.
  42. National Institute on Drug Abuse. Marijuana. [cited December 5, 2016]; Available from: https://www.drugabuse.gov/publications/marijuanaExternal
  43. Monte, A.A., R.D. Zane, and K.J. Heard, The implications of marijuana legalization in Colorado. JAMA, 2015. 313(3): p. 241-2.
  44. Wang, G.S., G. Roosevelt, and K. Heard, Pediatric marijuana exposures in a medical marijuana state. JAMA Pediatr, 2013. 167(7): p. 630-3.
  45. Berger, E., Legal marijuana and pediatric exposure pot edibles implicated in spike in child emergency department visits. Ann Emerg Med, 2014. 64(4): p. A19-21.
  46. National Institute on Drug Abuse. DrugFacts: Marijuana. [cited July 11 , 2016]; Available from: http://www.drugabuse.gov/publications/drugfacts/marijuanaExternal.
  47. Thompson, A.E., Medical Marijuana. JAMA, 2015. 313(24): p. 2508.
  48. Hancock-Allen, J.B., et al., Notes from the Field: Death Following Ingestion of an Edible Marijuana Product–Colorado, March 2014. MMWR Morb Mortal Wkly Rep, 2015. 64(28): p. 771-2.
  49. Stoll, D.B., Marijuana use in athletics. R I Med J (2013), 2015. 98(1): p. 13.
  50. MacCoun, R.J. and M.M. Mello, Half-baked–the retail promotion of marijuana edibles. N Engl J Med, 2015. 372(11): p. 989-91.
  51. Wang, G.S., et al., Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Ann Emerg Med, 2014. 63(6): p. 684-9.
  52. National Institute on Drug Abuse. Is marijuana a gateway drug? [cited July 11 ,2016]; Available from: http://www.drugabuse.gov/publications/marijuana/marijuana-gateway-drugExternal.
  53. National Institute on Drug Abuse, Preventing Drug Use among Children and Adolescents (In Brief). National Institutes of Health; U.S. Department of Health and Human Services.
  54. Natividad L, M.P., Parsons LH, Cannabinoid-alcohol interactions, in Cannabinoid Modulation of Emotion, Memory, and Motivation, P. Campolongo, Editor. 2013, Springer: New York, NY. p. 363-391.
  55. Hartman, R.L., et al., Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend, 2015. 154: p. 25-37.
  56. Dubois, S., et al., The combined effects of alcohol and cannabis on driving: Impact on crash risk. Forensic Sci Int, 2015. 248: p. 94-100.
  57. Peters, E.N., A.J. Budney, and K.M. Carroll, Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. Addiction, 2012. 107(8): p. 1404-17.
  58. Barsky, S.H., et al., Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst, 1998. 90(16): p. 1198-205.
  59. Fligiel, S.E., et al., Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest, 1997. 112(2): p. 319-26.
  60. Agrawal, A., A.J. Budney, and M.T. Lynskey, The co-occurring use and misuse of cannabis and tobacco: a review. Addiction, 2012. 107(7): p. 1221-33.
  61. Secades-Villa, R., et al., Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy, 2015. 26(2): p. 135-42.
  62. Panlilio, L.V., et al., Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology, 2013. 38(7): p. 1198-208.
  63. Levine, A., et al., Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med, 2011. 3(107): p. 107-9.
  64. Colorado Department of Public Health and Environment. Monitoring Health Concerns Related to Marijuana in Colorado: 2014. 2015 [cited 2016 July 11, 2016].
  65. Mark, K., A. Desai, and M. Terplan, Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Womens Ment Health, 2016. 19(1): p. 105-11.
  66. Warner, T.D., D. Roussos-Ross, and M. Behnke, It’s not your mother’s marijuana: effects on maternal-fetal health and the developing child. Clin Perinatol, 2014. 41(4): p. 877-94.
  67. Bloomfield, M.A., et al., The effects of Delta9-tetrahydrocannabinol on the dopamine system. Nature, 2016. 539(7629): p. 369-377.
  68. Macleod, J., et al., Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet, 2004. 363(9421): p. 1579-88.
  69. Fergusson, D.M. and J.M. Boden, Cannabis use and later life outcomes. Addiction, 2008. 103(6): p. 969-76; discussion 977-8.
  70. Brook, J.S., et al., Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus, 2013. 34(3): p. 298-305.
  71. Tang, Z. and R.G. Orwin, Marijuana initiation among American youth and its risks as dynamic processes: prospective findings from a national longitudinal study. Subst Use Misuse, 2009. 44(2): p. 195-211.
  72. Roditis, M.L. and B. Halpern-Felsher, Adolescents’ Perceptions of Risks and Benefits of Conventional Cigarettes, E-cigarettes, and Marijuana: A Qualitative Analysis. J Adolesc Health, 2015. 57(2): p. 179-85.
  73. Perez-Reyes, M., M.E. Wall, Presence of Δ9-tetrahydrocannabinol in human milk. N Engl J Med, 1982. 307(13): p. 819-20.
Esta página fue revisada el: 8 de mayo de 2017